Neurology Minute podcast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
15 Sekunden vorwärts
15 Sekunden vorwärts

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

Weitere Episoden von „Neurology Minute“